Patents by Inventor Ellen McMahon

Ellen McMahon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor
    Publication number: 20060003975
    Abstract: Novel methods and combinations for the treatment and/or prophylaxis of a pathologic condition in a subject, wherein the methods comprise the administration of one or more HMG Co-A reductase inhibitors and one or more aldosterone receptor antagonists, and the combinations comprise one or more HMG Co-A reductase inhibitors and one or more of said aldosterone receptor antagonists.
    Type: Application
    Filed: August 18, 2005
    Publication date: January 5, 2006
    Inventors: Bradley Keller, Ellen McMahon, Ricardo Rocha
  • Combination of an aldosterone receptor antagonist and an anti-diabetic agent
    Publication number: 20050014732
    Abstract: A combination therapy comprising a therapeutically-effective amount of an aldosterone receptor antagonist and a therapeutically-effective amount of an anti-diabetic agent is described for treatment of circulatory disorders, including cardiovascular disorders such as hypertension, congestive heart failure, cirrhosis and ascites. Preferred antidiabetic agents are those compounds having high potency and oral or parenteral bioavailability. Preferred aldosterone receptor antagonists are 20-spiroxane steroidal compounds characterized by the presence of a 9?,11?-substituted epoxy moiety.
    Type: Application
    Filed: January 30, 2004
    Publication date: January 20, 2005
    Applicant: Pharmacia Corporation
    Inventors: Eric Gulve, Ellen McMahon
  • Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
    Patent number: 6716829
    Abstract: Combinations of aldosterone blockers and Cyclooxygenase-2 inhibitors useful in the treatment of inflammation are disclosed.
    Type: Grant
    Filed: July 26, 2001
    Date of Patent: April 6, 2004
    Assignee: Pharmacia Corporation
    Inventors: Ricardo Rocha, Marc Zack, Ellen McMahon, Eileen R. Blasi
  • Aldosterone blocker therapy to prevent or treat inflammation-related disorders
    Publication number: 20030162759
    Abstract: Aldosterone blockers used for the treatment and prevention of inflammation are disclosed
    Type: Application
    Filed: July 26, 2001
    Publication date: August 28, 2003
    Inventors: Ricardo Rocha, Marc Zack, Ellen McMahon, Eileen R. Blasi
  • Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation- related cardiovascular disorders
    Publication number: 20030125312
    Abstract: Combinations of aldosterone blockers and Cyclooxygenase-2 inhibitors useful in the treatment of inflammation are disclosed.
    Type: Application
    Filed: July 26, 2001
    Publication date: July 3, 2003
    Inventors: Ricardo Rocha, Marc Zack, Ellen McMahon, Eileen R. Blasi